OasisLMS

Most MedTech failures happen before first-in-human, not because of bad technology, but because of the wrong preclinical strategy. Startups often overspend on data that doesn’t reduce regulatory risk or move them closer to clinical use. In this session, you’ll learn how to align preclinical, simulation, and regulatory strategy to move faster with less waste.